DNA stores the genetic instructions that build and maintain every living organism, while RNA reads, copies, and carries out those instructions in a variety of ways. That division of labor sounds tidy, but the reality is richer: DNA does more than just sit in the nucleus holding blueprints, and RNA does far more than shuttle messages to the protein-making machinery. Both molecules have structural, regulatory, and even catalytic roles that researchers are still mapping out.
DNA Stores Information in Two Ways
The most familiar function of DNA is encoding the sequences that specify proteins. Each stretch of DNA spells out a precise order of building blocks, and that order ultimately determines which protein gets made. But DNA also carries a second, less obvious layer of information embedded in its physical properties. The stiffness of a given stretch, how easily its two strands pull apart, and its tendency to bend or coil all vary depending on the local sequence. These physical traits influence how DNA interacts with the proteins that package it, read it, and repair it.
DNA’s ability to form a particular helical shape, B-DNA, gives it advantages over RNA for long-term storage. That structure makes the information encoded along the strand accessible to the cellular machinery that needs to read it, while also allowing the molecule to be wound tightly for compact storage. Under twisting stress, the helix can form supercoils, loops that help organize and compress the enormously long molecule so it fits inside a cell.1PubMed Central. DNA structure and function
Copying the Genome Without Losing the Message
Every time a cell divides, all of its DNA has to be duplicated. The human genome contains roughly three billion base pairs per copy, so the copying machinery needs to be both fast and accurate. Specialized enzymes called DNA polymerases handle the job, and they achieve remarkable precision through a multi-step quality control system. First, the polymerase selects the correct building block to add, rejecting mismatches most of the time. When a wrong one slips in, a built-in proofreading function catches the error and removes it. This proofreading alone improves accuracy by about a hundred- to a thousandfold.2PubMed Central. Fidelity of DNA replication-a matter of proofreading
The proofreading process works through a kind of back-and-forth shuttle. The polymerase detects a mismatch at its active site, then shifts the newly made strand over to a separate site that clips off the wrong base. Once the offending piece is removed, the strand slides back to the building site, and normal copying resumes. Structural studies have shown that this shuttling involves unwinding several base pairs of the fresh double helix so the mismatched end can reach the editing site.3PubMed Central. The proofreading mechanism of the human leading-strand DNA polymerase ε holoenzyme Researchers have described the overall motion as a “bolt-action” mechanism, where the primer tip cycles back and forth between the two catalytic sites without the enzyme ever letting go of the DNA.4Nature Communications. Structural basis for DNA proofreading
After replication finishes, a third safety net kicks in. A mismatch repair system scans the newly copied DNA, finds any remaining errors, and fixes them. Together, the three tiers of quality control reduce the error rate to roughly one mistake per billion bases copied per cell division, which is low enough to keep genomes stable across countless rounds of cell division.
Fitting Two Meters of DNA Into a Microscopic Nucleus
If you stretched out all the DNA in a single human cell, it would measure about two meters. Cells solve this packaging problem by wrapping DNA around clusters of proteins called histones, forming bead-like units called nucleosomes. These nucleosomes then fold into higher-order structures, progressively compacting the material. Imaging studies using electron tomography have shown that chromatin in living cells is not the neat, rigid hierarchy that textbook diagrams suggest. Instead, it forms a flexible, irregularly folded chain between about 5 and 24 nanometers in diameter, packed at different densities depending on whether the cell is dividing or going about its normal business.5PubMed Central. ChromEMT: Visualizing 3D chromatin structure and compaction in interphase and mitotic cells
The way nucleosomes are spaced along the DNA affects more than just packing. Changes in nucleosome positioning ripple upward, reshaping how the chromatin folds into larger domains and influencing which genes are accessible for reading. Research has demonstrated a “bottom-up” relationship: when nucleosome-level properties change, short-range contacts between nearby DNA segments weaken, domain boundaries soften, and the overall three-dimensional organization shifts.6PubMed Central. Genome wide nucleosome landscape shapes 3D chromatin organization Packaging, in other words, is not just about fitting DNA into a tight space. It is a regulatory tool that controls which parts of the genome are open for business.
RNA as Messenger, Adapter, and Catalyst
The best-known type of RNA is messenger RNA, or mRNA. When a gene needs to be expressed, the cell copies that stretch of DNA into an mRNA molecule, which then travels to the ribosome, the cell’s protein-building machine. There, the sequence of the mRNA is read in three-letter chunks, each specifying a particular amino acid. But mRNA is only one player in the translation process.
Transfer RNA, or tRNA, is the adapter that physically matches each three-letter code word to the correct amino acid. One end of the tRNA reads the mRNA code; the other end carries the corresponding amino acid. Without tRNA, there would be no way to convert a nucleic acid sequence into a protein sequence.7PubMed Central. Transfer RNAs: diversity in form and function The tRNA family is surprisingly diverse, with hundreds of variants in the human genome that differ in structure and chemical modifications, giving the cell fine control over how efficiently different proteins are produced.
The ribosome itself is where the story gets especially interesting. The ribosome is made mostly of ribosomal RNA, or rRNA, and the active site where new protein bonds are actually formed is built entirely from RNA, with no protein side chains anywhere nearby. Structural studies found that the nearest protein atoms are about 18 angstroms away from the site where the peptide bond forms.8PubMed. The structural basis of ribosome activity in peptide bond synthesis That makes the ribosome a ribozyme: an RNA molecule that catalyzes a chemical reaction. It is the largest known RNA catalyst and the only natural one that builds something rather than breaking something apart.9Trends in Biochemical Sciences. Mechanism of peptide bond formation on the ribosome
Detailed work on the peptide-bond-forming center has identified specific chemical groups in the rRNA that are critical for catalysis. A particular hydroxyl group on the rRNA residue A2451 acts as a hydrogen donor, helping to position the substrates and promote bond formation through a proton shuttle mechanism.10Chemistry & Biology. The Role of 23S Ribosomal RNA Residue A2451 in Peptide Bond Synthesis Revealed by Atomic Mutagenesis The fact that RNA, not protein, does the heavy lifting at the heart of protein synthesis is one of the strongest pieces of evidence for the idea that RNA preceded proteins in the early history of life.
RNA That Never Becomes Protein
A large fraction of the RNA a cell produces never encodes a protein at all. These non-coding RNAs have regulatory jobs, and the variety of mechanisms they use is still expanding.
Small RNA molecules, including microRNAs and small interfering RNAs, regulate gene expression by guiding a protein complex called RISC to specific mRNA targets. Once RISC latches onto an mRNA, it can either chop it up or block it from being translated into protein. The system can be programmed to silence virtually any gene, which is what makes it such a powerful tool both for the cell and for researchers who want to study gene function.11PubMed Central. The RNA-induced silencing complex: a versatile gene-silencing machine
Long non-coding RNAs, defined loosely as those longer than 200 nucleotides, operate differently. Rather than targeting individual mRNAs for destruction, they can act as signals, decoys, guides, or scaffolds that organize larger protein complexes.12PubMed Central. Molecular mechanisms of long noncoding RNAs One well-studied example, a long non-coding RNA called HOTAIR, simultaneously binds two different protein complexes involved in modifying histones. By tethering both complexes together, HOTAIR coordinates changes on the same stretch of chromatin, effectively acting as a platform for rewriting the chemical marks that control whether nearby genes are on or off.13PubMed Central. Long noncoding RNA as modular scaffold of histone modification complexes This scaffold function was unexpected and illustrated that RNA can play architectural roles in the nucleus, not just informational ones.
Chemical Marks on DNA and RNA That Change Gene Behavior
The sequence of DNA is not the only thing that matters for gene expression. Chemical modifications added on top of the sequence, without changing the underlying letters, can turn genes on or off. The most studied of these modifications is DNA methylation, where a small chemical group is attached to certain bases. Methylation is a major driver of gene silencing: heavily methylated genes tend to be shut down. The proteins responsible for adding methyl groups also recruit enzymes that modify histones, tightening the packaging and further locking genes into a silent state.14PubMed Central. DNA methylation and histone deacetylation in the control of gene expression: basic biochemistry to human development and disease Together, DNA methylation and histone modifications form overlapping layers of regulation that influence processes from DNA repair and replication to cell growth.15PubMed Central. The role of DNA methylation and histone modifications in transcriptional regulation in humans
RNA gets its own set of chemical modifications, too, a field now called epitranscriptomics. More than a hundred different modifications have been found on various RNA molecules, but one of the most abundant on mRNA is a methyl group added to adenosine, known as m6A. These marks affect how stable an mRNA molecule is, where it ends up inside the cell, and how efficiently it gets translated into protein.16PubMed Central. Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives Evidence is accumulating that m6A methylation matters for cancer biology and aging, and there are strong indications that it plays a role in embryonic development, although exactly how it contributes to normal versus abnormal development is still being worked out.17PubMed. Regulatory role of m(6)A epitranscriptomic modifications in normal development and congenital malformations during embryogenesis
DNA Damage and the Systems That Repair It
DNA is constantly under attack. Ultraviolet light, reactive chemicals produced by normal metabolism, and environmental toxins all damage the molecule in different ways: breaking one or both strands, altering individual bases, or creating cross-links between strands. Cells have evolved multiple overlapping repair pathways to deal with this steady stream of damage.18PubMed Central. Mechanisms of DNA damage, repair, and mutagenesis
The most dangerous type of lesion is a double-strand break, where both rails of the DNA helix are severed. If left unrepaired, these breaks can cause chromosomes to rearrange or lose pieces, which can lead to cell death or cancer. One major repair pathway, homologous recombination, fixes double-strand breaks by using the intact copy on the sister chromosome as a template. The process involves searching the genome for a matching sequence, threading the broken strand into the intact double helix, copying the missing information, and then restoring the original structure.19PubMed Central. Homologous recombination and the repair of DNA double-strand breaks It is an elaborate choreography, but it preserves the original sequence with high accuracy.
Telomeres and the Ends of Chromosomes
Linear chromosomes have a structural problem: their tips look a lot like broken DNA ends, and repair enzymes might try to fuse them together, causing havoc. Telomeres solve this by capping each chromosome end with repetitive sequences and specialized proteins that signal “this is not a break.” They also cushion the genome against the inherent shortening that occurs every time DNA is copied, because the replication machinery cannot fully duplicate the very end of a linear molecule.20PubMed Central. Telomeres and Cell Senescence – Size Matters Not
As telomeres shorten with each cell division, they eventually reach a critical length, and the cell enters a permanent growth arrest known as replicative senescence. This process is thought to be one mechanism behind aging at the tissue level. Cancer cells typically bypass this limit by activating telomerase, an enzyme that rebuilds telomeres. The guanine-rich overhang at the end of a telomere can fold into unusual structures called G-quadruplexes, which block telomerase from extending the telomere. Researchers have explored drugs that stabilize these structures as a potential anticancer strategy: in laboratory experiments, treating tumor cells with G-quadruplex-stabilizing agents caused telomere erosion and triggered the senescent phenotype.21PubMed Central. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands
Non-Canonical DNA Structures and Cancer
The G-quadruplexes mentioned above are just one example of DNA adopting shapes beyond the classic double helix. Guanine-rich stretches can stack into four-stranded structures, while cytosine-rich stretches on the opposite strand can form their own unusual folds called i-motifs. These structures are not rare curiosities. They tend to form in the regulatory regions upstream of genes, and they have been closely linked to cancer development because of their ability to dial gene expression up or down.22PubMed. Switching off cancer – An overview of G-quadruplex and i-motif functional role in oncogene expression Drugs designed to lock these structures in place could, in theory, shut down cancer-driving genes at the DNA level, which is a fundamentally different approach from targeting the proteins those genes produce.
RNA Outside the Cell
For decades, RNA was thought of as an exclusively intracellular molecule, too fragile to survive in the bloodstream. It turns out that cells routinely release RNA into their surroundings, packaged inside tiny membrane-bound vesicles or bound to protective proteins. These extracellular RNAs travel through blood, saliva, urine, and other body fluids, and they carry information about the state of the cells that released them.23PubMed Central. Extracellular RNA as a kind of communication molecule and emerging cancer biomarker Some of these RNAs appear to function as communication molecules, taken up by distant cells where they influence gene expression, a form of cell-to-cell signaling that was not appreciated until recently.24PubMed Central. Multifaceted roles of extracellular RNAs in different diseases
From a medical standpoint, circulating nucleic acids are opening a door to what clinicians call liquid biopsies. Tumor cells shed fragments of their DNA and RNA into the blood, and detecting these fragments allows doctors to monitor tumor burden, track how a cancer evolves, and identify drug resistance without needing a surgical biopsy. Circulating tumor nucleic acids are being explored for diagnosis, prognosis, and treatment guidance across many cancer types.25PubMed Central. Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance
When Viruses Use RNA as Their Genome
Although DNA is the standard information-storage molecule for cellular life, many viruses store their genomes as RNA instead. Retroviruses take this a step further: they carry an RNA genome but use an enzyme called reverse transcriptase to convert that RNA into DNA, which then gets stitched into the host cell’s chromosomes.26PubMed Central. Retroviral reverse transcriptases This integration is what makes retroviruses so persistent. Once the viral DNA is part of your genome, it gets copied every time your cells divide.27PubMed Central. Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication
Hepatitis B virus uses a related but distinct strategy. Rather than using a separate RNA primer to start DNA synthesis, the viral polymerase itself acts as the primer. It binds a small RNA hairpin structure on the viral RNA, synthesizes a short DNA fragment covalently attached to the protein, and then that fragment detaches and re-anneals to a different part of the RNA genome before full-length DNA synthesis continues. The same RNA hairpin also serves as the signal for packaging the viral RNA into new virus particles, an elegant economy where one structure handles two completely different tasks.28PubMed Central. Novel mechanism for reverse transcription in hepatitis B viruses
The existence of reverse transcriptase overturned the old assumption that information flows only from DNA to RNA to protein. It also gave the discovery of reverse transcription an enormous afterlife in biotechnology, because the enzyme is now a workhorse tool for converting RNA samples into DNA for sequencing and analysis.
RNA’s Deep Evolutionary Past
The fact that RNA can both store information and catalyze reactions points to a time before DNA and proteins existed. The “RNA world” hypothesis proposes that early life relied on RNA molecules, ribozymes, to handle both jobs.29PubMed. Evolution of ribozymes in an RNA world The ribosome’s RNA-only active site, described earlier, is considered a molecular fossil of that era: a catalytic RNA so successful that evolution never replaced it with a protein enzyme, even after billions of years.
Nucleic Acids as Medicine
Understanding the functions of DNA and RNA has led to a new class of therapies built from nucleic acids themselves. mRNA vaccines, which deliver a temporary set of instructions to cells so they produce a target protein and train the immune system, are the most visible example. Beyond vaccines, researchers are developing mRNA-driven gene-editing treatments that deliver the instructions for the CRISPR-Cas9 editing machinery directly as mRNA rather than as a permanent DNA insert, sidestepping the risk of integrating foreign DNA into the patient’s genome. The tradeoff is that mRNA is inherently unstable, triggers immune responses, and has a short working life inside cells, all of which limit how well these therapies work in practice.30Molecular Therapy Nucleic Acids. Enhancing mRNA stability and translation efficiency for mRNA-driven CRISPR-Cas9 therapeutics
The broader toolkit extends well beyond mRNA. Antisense oligonucleotides that bind to and silence specific mRNAs, small interfering RNAs that harness the RISC pathway described earlier, and DNA-based gene therapies that replace defective genes are all either approved or in advanced clinical trials. Tissue-targeted delivery systems, often using specialized chemical attachments or nanoparticles, are pushing these therapies toward more precise action with fewer off-target effects.31Nature Nanotechnology. The current landscape of nucleic acid therapeutics The common thread is that once you understand what DNA and RNA do inside a cell, you can co-opt those same functions and pathways to treat disease, sometimes by adding instructions, sometimes by silencing them, and sometimes by editing the master copy itself.